AL ANAESTHESIA LTD
- · Thesis: well-run, low negotiation leverage
Opportunity 79/100 (strong), bankability 75/100. Strong seller-intent signal (68/100, director aged 71). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Average employees | 200 | 200 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (24 events)Click to expand
- 2025-12-23📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-12-16📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-12-20📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-12-13📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-12-09📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-01-05📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-12-23📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-12-20📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-12-22📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2016-11-28📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2016-01-29📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2016-01-27📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-01-22📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2014-12-24📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2014-02-10📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2013-10-11➕LEE, Janette Margaret appointeddirector
- 2012-03-31➕LEE, Alistair, Dr appointeddirector
- 2012-03-31➖MORTON FRASER SECRETARIES LIMITED resignedcorporate-secretary
- 2012-03-31➖BELL, Adrian Edward Robert resigneddirector
- 2012-03-31➖MORTON FRASER DIRECTORS LIMITED resignedcorporate-director
- 2012-02-22🏢Company incorporatedAs AL ANAESTHESIA LTD
- 2012-02-22➕MORTON FRASER SECRETARIES LIMITED appointedcorporate-secretary
- 2012-02-22➕BELL, Adrian Edward Robert appointeddirector
- 2012-02-22➕MORTON FRASER DIRECTORS LIMITED appointedcorporate-director
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Founder age: Director aged approximately 71 — succession pressure is live.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 70+: Senior director is approximately 71 years old. Natural succession window is now.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
- secondary12+ year tenure: Director in role 14 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Alistair Lee Individual · British · DOB 11/1955 · age 71 | 50–75% | 75–100% | board control75-100% shares · 75-100% voting · board control | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A.E.N. LIMITED→ SC256550 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
| AADENT 1 LIMITED→ SC868082 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ACUPUNCTURE & HEALTH CENTRE LTD→ SC383161 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| AD MEDICAL LIMITED→ SC630065 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ADHDDEGREE LTD→ SC822923 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AGASACK LIMITED→ SC586663 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| AGE ETERNAL LIMITED→ SC767087 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AGE SCOTLAND→ SC153343 · est 1994 · no financials extracted | — | — | — | — | 31y | — | — |
| AHMSO LIMITED→ SC487979 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| AILSA CARE SERVICES LTD.→ SC272779 · est 2004 · no financials extracted | — | — | — | — | 21y | — | — |
| AL-AFFAN LIMITED→ SC727290 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ALANDO LIMITED→ SC853026 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 3 resigned)
Click a director name to see their full track record across all companies.